Wiskott-Aldrich Syndrome is an x-linked immunodeficiency condition charac-terized by microthrombocytopenia, eczema and recurrent infections. It is caused by mutations in the Wiskott Aldrich Protein (WASP) gene. Hereby we report a 13-month-old Yemeni male infant with mutation in WASP Gene, who presented with congenital microthrombocytopenia, eczema, bleeding tendency and recurrent infections. The variant found in this case creates a shift in the reading frame located in the exon 10 of WAS gene. These variants were also detected in the child’s mother in heterozygous state.
Cite this paper
Thabet, S. , Kassim, A. , Al-Jomaai, N. , Alathwary, R. and Alhalemi, S. (2019). Clinical and Molecular Characters of a Yemeni Child with Wiskott-Aldrich Syndrome. Open Access Library Journal, 6, e5235. doi: http://dx.doi.org/10.4236/oalib.1105235.
Derry, J.M., Ochs, H.D. and Francke, U. (1994) Isolation of a Novel Gene Mutated in Wiskott-Aldrich Syn-drome. Cell, 78, 635-644. https://doi.org/10.1016/0092-8674(94)90528-2
Orange, J.S., Stone, K.D., Turvey, S.E. and Krzewski, K. (2004) The Wiskott-Aldrich Syndrome. Cellular and Molecular Life Sciences, 61, 2361-2385. https://doi.org/10.1007/s00018-004-4086-z
Thrasher, A.J. (2009) New Insights into the Biology of Wiskott-Aldrich Syndrome (WAS). Hematology. American Society of Hematology. Education Program, 132-138. https://doi.org/10.1182/asheducation-2009.1.132
Imai, K., Morio, T., Zhu, Y., et al. (2004) Clinical Course of Patients with WASP Gene Mutations. Blood, 103, 456-464. https://doi.org/10.1182/blood-2003-05-1480
Ozsahin, H., Cavazza-na-Calvo, M., Notarangelo, L.D., et al. (2008) Long-Term Outcome Following Hem-atopoietic Stem-Cell Transplantation in Wiskott-Aldrich Syndrome: Collaborative Study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood, 111, 439-445. https://doi.org/10.1182/blood-2007-03-076679
Itoh, S., Nonoyama, S., Morio, T., et al. (2000) Mutations of the WASP Gene in 10 Japanese Patients with Wiskott-Aldrich Syndrome and X-Linked Thrombocytopenia. International Journal of Hematology, 71, 79-83.
Harfi, H.A., Al-Malik, S. and Tulba, A. (1992) Wis-kott-Aldrich Syndrome. Annuals of Saudi Medicine, 12, 355-361. https://doi.org/10.5144/0256-4947.1992.355
Standen, G.R. (1988) Wis-kott-Aldrich Syndrome: New Perspective in Pathogenesis and Management. Journal of the Royal College of Physicians of London, 22, 80-83.
Perry, G.S., Schuman, L.M., McHugh, R.B., et al. (1980) The Wiskott-Aldrich Syndrome in the United States and Canada (1892-1979). The Journal of Pediatrics, 97, 72-78. https://doi.org/10.1016/S0022-3476(80)80133-8
Rosen, F.S., Cooper, M.D. and Wedgwood, R.G.P. (1984) The Primary Immunodeficiencies. The New England Journal of Medicine, 311, 300-310. https://doi.org/10.1056/NEJM198408023110506
Jin, Y., Mazza, C., Christie, J.R., et al. (2004) Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): Hotspots, Effect on Transcription, and Translation and Phenotype/Genotype Correlation. Blood, 104, 4010-4019. https://doi.org/10.1182/blood-2003-05-1592
Ochs, H.D. and Thrasher, A.J. (2006) The Wiskott-Aldrich Syndrome. Journal of Allergy and Clinical Immunology, 117, 725-736. https://doi.org/10.1016/j.jaci.2006.02.005
Good, R.A. (1987) Bone Marrow Transplantation for Immunodeficiency Disease. The American Journal of the Medical Sciences, 294, 68-74. https://doi.org/10.1097/00000441-198708000-00002
Baharin, M.F., Kader Ibrahim, S.B., Yap, S.H., Abdul Manaf, A.M., Mat Ripen, A. and Dhaliwal, J.S. (2015) Molecular Characterization of Two Malaysian Patients with Wiskott-Aldrich Syn-drome. Malaysian Journal of Pathology, 37, 153-158.